Албена Тодорова

1.2k total citations
71 papers, 661 citations indexed

About

Албена Тодорова is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Албена Тодорова has authored 71 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 19 papers in Genetics and 6 papers in Surgery. Recurrent topics in Албена Тодорова's work include Muscle Physiology and Disorders (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (12 papers) and Genetics and Neurodevelopmental Disorders (8 papers). Албена Тодорова is often cited by papers focused on Muscle Physiology and Disorders (13 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (12 papers) and Genetics and Neurodevelopmental Disorders (8 papers). Албена Тодорова collaborates with scholars based in Bulgaria, Germany and Italy. Албена Тодорова's co-authors include Tihomir Todorov, Vanio Mitev, Ivo Kremensky, Jürgen Horst, Arseni Markoff, Ivailo Tournev, Iliyana Pacheva, Иван Иванов, Gian Antonio Danieli and Andrey Kirov and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Human Molecular Genetics.

In The Last Decade

Албена Тодорова

59 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Албена Тодорова Bulgaria 14 363 132 128 63 55 71 661
Carmen Sílvia Bertuzzo Brazil 22 210 0.6× 104 0.8× 46 0.4× 117 1.9× 59 1.1× 81 1.1k
Saixia Ying United States 13 619 1.7× 132 1.0× 43 0.3× 31 0.5× 65 1.2× 27 949
Juan J. Haro‐Mora United States 18 474 1.3× 189 1.4× 95 0.7× 95 1.5× 167 3.0× 33 909
Andreas Glenthøj Denmark 15 178 0.5× 104 0.8× 235 1.8× 50 0.8× 163 3.0× 73 907
Sarah L. N. Clarke United Kingdom 10 315 0.9× 52 0.4× 188 1.5× 52 0.8× 13 0.2× 23 649
İsmail Okan Türkiye 15 554 1.5× 73 0.6× 31 0.2× 115 1.8× 28 0.5× 35 1.0k
Linda Gailīte Latvia 12 155 0.4× 142 1.1× 17 0.1× 36 0.6× 58 1.1× 67 437
Neil A. Hanchard United States 20 401 1.1× 354 2.7× 242 1.9× 99 1.6× 255 4.6× 54 1.2k
Nobuyasu Baba Japan 16 215 0.6× 50 0.4× 41 0.3× 64 1.0× 47 0.9× 22 940
Myung Seo Kang South Korea 15 224 0.6× 39 0.3× 84 0.7× 87 1.4× 167 3.0× 42 833

Countries citing papers authored by Албена Тодорова

Since Specialization
Citations

This map shows the geographic impact of Албена Тодорова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Албена Тодорова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Албена Тодорова more than expected).

Fields of papers citing papers by Албена Тодорова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Албена Тодорова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Албена Тодорова. The network helps show where Албена Тодорова may publish in the future.

Co-authorship network of co-authors of Албена Тодорова

This figure shows the co-authorship network connecting the top 25 collaborators of Албена Тодорова. A scholar is included among the top collaborators of Албена Тодорова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Албена Тодорова. Албена Тодорова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gresham, David, Velina Guergueltcheva, Teodora Chamova, et al.. (2024). Phenotypic Variability of LGMD 2C/R5 in a Genetically Homogenous Group of Bulgarian Muslim Roma. Genes. 15(9). 1144–1144.
3.
Georgieva, Bilyana, et al.. (2024). MiRNA Signatures Related to Invasiveness and Recurrence in Patients With Non-Functioning Pituitary Neuroendocrine Tumors. Experimental and Clinical Endocrinology & Diabetes. 132(5). 240–248.
4.
Georgieva, Bilyana, et al.. (2023). Bacterial and Viral Pathogens Implicated in Female Reproductive Failure Investigated on Menstrual Blood. Proceedings of the Bulgarian Academy of Sciences. 76(3). 394–406. 2 indexed citations
5.
Velchev, Vasil, et al.. (2023). Novel insights on GTPBP3‐associated hypertrophic cardiomyopathy. American Journal of Medical Genetics Part A. 191(7). 1804–1813. 1 indexed citations
6.
Spiriev, Toma, et al.. (2023). miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets. Non-coding RNA Research. 9(1). 141–152. 13 indexed citations
7.
Господинова, Мариана, Stayko Sarafov, Teodora Chamova, et al.. (2020). Cardiac involvement, morbidity and mortality in hereditary transthyretin amyloidosis because of p.Glu89Gln mutation. Journal of Cardiovascular Medicine. 21(9). 688–695. 8 indexed citations
8.
Todorov, Tihomir, et al.. (2017). Wolman Disease in Bulgarian Patients: Selective Genetic Screening in Two Presumable Endemic Regions. American Journal of Molecular Biology. 7(4). 169–175. 2 indexed citations
9.
Todorov, Tihomir, Албена Тодорова, Iglika Yordanova, et al.. (2015). First cases of pyridoxine-dependent epilepsy in Bulgaria: novel mutation in the ALDH7A1 gene. Neurological Sciences. 36(12). 2209–2212. 5 indexed citations
10.
Kirov, Andrey, Petia Dimova, Албена Тодорова, et al.. (2013). 15q13.3 microdeletions in a prospectively recruited cohort of patients with idiopathic generalized epilepsy in Bulgaria. Epilepsy Research. 104(3). 241–245. 7 indexed citations
11.
Litvinenko, Ivan, et al.. (2013). One Novel and One Recurrent Mutation in IGHMBP2 Gene, Causing Severe Spinal Muscular Atrophy Respiratory Distress 1 With Onset Soon After Birth. Journal of Child Neurology. 29(6). 799–802. 6 indexed citations
12.
Dimova, Petia, Andrey Kirov, Албена Тодорова, Tihomir Todorov, & Vanio Mitev. (2012). A Novel PCDH19 Mutation Inherited From an Unaffected Mother. Pediatric Neurology. 46(6). 397–400. 21 indexed citations
13.
Todorov, Tihomir, Албена Тодорова, Petia Dimova, et al.. (2012). Spontaneous recurrent mutations and a complex rearrangement in the MECP2 gene in the light of current models of mutagenesis. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 734(1-2). 69–72. 1 indexed citations
14.
Тодорова, Албена, et al.. (2012). Different methylation patterns in BWS/SRS cases clarified by MS-MLPA. Molecular Biology Reports. 40(1). 263–268. 3 indexed citations
15.
Kirov, Andrey, et al.. (2010). Toll-Like Receptor (TLR2 and TLR4) Polymorphisms: Markers of Innate Immunity in Oral Infection in Children. Oral Health and Dental Management. 2010(3). 0–0. 2 indexed citations
16.
Тодорова, Албена, Bilyana Georgieva, Ivailo Tournev, et al.. (2007). A large deletion and novel point mutations in the calpain 3 gene (CAPN3) in Bulgarian LGMD2A patients. Neurogenetics. 8(3). 225–229. 23 indexed citations
17.
Bogdanova, Nadja, Arseni Markoff, Ulrike Nowak‐Göttl, et al.. (2005). Spectrum of molecular defects and mutation detection rate in patients with severe hemophilia A. Human Mutation. 26(3). 249–254. 34 indexed citations
18.
Тодорова, Албена, et al.. (2003). Dilated cardiomyopathy and new 16 bp deletion in exon 44 of the dystrophin gene: The possible role of repeated motifs in mutation generation. American Journal of Medical Genetics Part A. 120A(1). 5–7. 8 indexed citations
19.
Тодорова, Албена, Angel Ashikov, Olga Beltcheva, Ivailo Tournev, & Ivo Kremensky. (1999). C283Y mutation and other C-terminal nucleotide changes in the ?-sarcoglycan gene in the Bulgarian gypsy population. Human Mutation. 14(1). 40–44. 13 indexed citations
20.
Тодорова, Албена & Gian Antonio Danieli. (1997). Large majority of single‐nucleotide mutations along the dystrophin gene can be explained by more than one mechanism of mutagenesis. Human Mutation. 9(6). 537–547. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026